ACIU — AC Immune SA
AC Immune SA (ACIU) is listed on NASDAQ.
Its activity is classified under HEALTHCARE, in the BIOTECHNOLOGY industry.
Searching for the AC Immune SA share price, or whether to buy ACIU? This page brings together a live chart, momentum and risk scores, fresh news and community sentiment.
VAQO runs a statistical model over ACIU that reads seven technical indicators and translates them into an opportunity score and a risk score — including which factors drove them.
What ACIU is
AC Immune SA, a clinical-stage biopharmaceutical company, discovers, designs and develops drugs and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. The company is headquartered in Lausanne, Switzerland.…
AC Immune SA is classified under HEALTHCARE, in the BIOTECHNOLOGY industry.
It trades on NASDAQ as a common stock.
ACIU size and valuation
At roughly $250.6M, ACIU is a micro-cap.
Earnings per share are negative at -0.54, so there is no meaningful price-to-earnings multiple to quote.
Beta is 1.55: historically it has moved more than the market.
ACIU over the past year
Over the past year ACIU has traded between $2.10 and $4.00, and the current price sits at 7% of that range.
Trading near the low end of a 52-week range is a different situation from a bad day: it means the year, not the session, has gone against it.
The 50-day average is $2.61 against a 200-day average of $2.81 — the shorter average sits below the longer one, usually read as a downtrend.
The published analyst target is $8.52, 282.1% above it. A target is an aggregate of opinions, not a measurement.
How AC Immune SA (ACIU) is trading
AC Immune SA (ACIU) is up 5.69% at $2.23. A move that large in a single session sits well outside the normal daily range for most stocks.
The session ranged from $2.10 to $2.25 — 7.0% of the share price — and the current price sits at 87% of that range.
It opened at 3% of the daily range and finished at 87% of it: ACIU turned around inside the session, in the buyers' favour.
Volume ran near 180.4K shares, about $402.3K of stock changing hands.
Traded alongside ACIU
Names traded alongside ACIU in the same sector: A (Agilent Technologies Inc), AAPG (Ascentage Pharma Group International), AARD (Aardvark Therapeutics Inc), ABCL (AbCellera Biologics Inc), ABEO (Abeona Therapeutics Inc).
What VAQO's model says about ACIU
Two statistical models run over ACIU inside the browser, reporting momentum, risk and opportunity separately. Full accuracy for both, including when it falls, is published on the model page.
Key facts
- Symbol: ACIU
- Name: AC Immune SA
- Sector: HEALTHCARE
- Industry: BIOTECHNOLOGY
- Exchange: NASDAQ
- Instrument: Stock
ACIU — frequently asked questions
What is the market cap of ACIU?
AC Immune SA has a market capitalisation of roughly $250.6M.
What is the 52-week range for ACIU?
ACIU has traded between $2.10 and $4.00 over the past year, with the current price at 7% of that range.
How much does ACIU stock cost today?
AC Immune SA (ACIU) trades at $2.23, a change of +5.69% in the latest session.
Is ACIU up or down today?
ACIU is up 5.69% in the latest session, at $2.23.
What is the daily trading range for ACIU?
ACIU traded between $2.10 and $2.25 in the latest session, and currently trades at $2.23.
What is the trading volume for ACIU?
ACIU traded roughly 180.4K shares in the latest session.
Which exchange is ACIU listed on?
ACIU is listed on NASDAQ, in the HEALTHCARE sector.
Should I buy ACIU stock?
VAQO gives no buy or sell recommendations and is not an investment adviser. The ACIU figures on this page — price, range, volume and the model's scores — are there to inform your decision, not to stand in for it.
Others in HEALTHCARE
- A — Agilent Technologies Inc
- AAPG — Ascentage Pharma Group International
- AARD — Aardvark Therapeutics Inc
- ABCL — AbCellera Biologics Inc
- ABEO — Abeona Therapeutics Inc
- ABOS — Acumen Pharmaceuticals Inc
Last updated: 2026-11-08